tradingkey.logo
搜尋

Integra Lifesciences Holdings Corp

IART
添加自選
14.100USD
-0.400-2.76%
收盤 05/15, 16:00美東報價延遲15分鐘
1.10B總市值
虧損本益比TTM

Integra Lifesciences Holdings Corp

14.100
-0.400-2.76%

關於 Integra Lifesciences Holdings Corp 公司

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp簡介

公司代碼IART
公司名稱Integra Lifesciences Holdings Corp
上市日期Aug 16, 1995
CEOPoul (Mojdeh)
員工數量4396
證券類型Ordinary Share
年結日Aug 16
公司地址1100 Campus Road
城市PRINCETON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編08540
電話16092750500
網址https://www.integralife.com/
公司代碼IART
上市日期Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%
地區USD
名稱
營收
佔比
United States
1.20B
73.67%
Asia Pacific
189.25M
11.57%
Europe
162.67M
9.95%
Rest of World
78.58M
4.81%
業務
地區
業務USD
名稱
營收
佔比
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%

股東統計

更新時間: 5月13日 週三
更新時間: 5月13日 週三
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.09%
TRU ST Partnership, L.P.
10.95%
Rubric Capital Management LP
9.97%
Vanguard Portfolio Management, LLC
4.74%
Fuller & Thaler Asset Management Inc.
4.67%
其他
57.59%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.09%
TRU ST Partnership, L.P.
10.95%
Rubric Capital Management LP
9.97%
Vanguard Portfolio Management, LLC
4.74%
Fuller & Thaler Asset Management Inc.
4.67%
其他
57.59%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
37.70%
Investment Advisor
36.17%
Hedge Fund
17.97%
Corporation
10.95%
Research Firm
3.47%
Individual Investor
3.46%
Pension Fund
1.65%
Bank and Trust
0.48%
Family Office
0.14%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
574
82.80M
106.43%
-14.51M
2025Q4
584
74.73M
95.94%
-24.99M
2025Q3
583
73.55M
94.42%
-25.07M
2025Q2
600
89.38M
114.72%
-18.72M
2025Q1
635
87.01M
111.97%
-18.30M
2024Q4
636
81.93M
106.10%
-20.27M
2024Q3
638
82.93M
106.93%
-12.58M
2024Q2
628
84.82M
107.92%
-1.75M
2024Q1
613
79.36M
101.18%
-3.69M
2023Q4
597
79.81M
101.26%
-5.74M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
9.40M
12.07%
+117.91K
+1.27%
Dec 31, 2025
TRU ST Partnership, L.P.
8.52M
10.93%
--
--
Feb 28, 2025
Rubric Capital Management LP
7.75M
9.95%
+100.00K
+1.31%
Dec 31, 2025
Fuller & Thaler Asset Management Inc.
3.64M
4.67%
-278.08K
-7.10%
Dec 31, 2025
Invesco Advisers, Inc.
3.18M
4.08%
-1.27K
-0.04%
Dec 31, 2025
State Street Investment Management (US)
2.81M
3.61%
+21.72K
+0.78%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
3.09M
3.96%
-96.93K
-3.04%
Dec 31, 2025
Boston Management and Research
2.74M
3.52%
--
--
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
1.44%
State Street SPDR S&P Health Care Equipment ETF
1.39%
ROBO Global Healthcare Technology & Innovation ETF
1.02%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
Royce Quant Small-Cap Quality Value ETF
0.13%
Principal U.S. Small-Cap ETF
0.13%
iShares S&P Small-Cap 600 Value ETF
0.12%
State Street SPDR S&P 600 Small Cap Value ETF
0.11%
查看更多
iShares Neuroscience and Healthcare ETF
佔比1.44%
State Street SPDR S&P Health Care Equipment ETF
佔比1.39%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.02%
Invesco S&P SmallCap Health Care ETF
佔比0.49%
Invesco NASDAQ Future Gen 200 ETF
佔比0.43%
Inspire Small/Mid Cap ESG ETF
佔比0.19%
Royce Quant Small-Cap Quality Value ETF
佔比0.13%
Principal U.S. Small-Cap ETF
佔比0.13%
iShares S&P Small-Cap 600 Value ETF
佔比0.12%
State Street SPDR S&P 600 Small Cap Value ETF
佔比0.11%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI